These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Clinical use of interferon and its inducers]. Nosik NN; Ershov FI Antibiotiki; 1980 Sep; 25(9):695-710. PubMed ID: 6158289 [No Abstract] [Full Text] [Related]
4. [Determination of the interferon level in the blood, conjunctival washings and urine of patients with herpetic keratoiridocyclitis treated with interferonogen]. Zeĭtlenok NA; Konosh OV; Kasparov AA; Fadeeva LL Antibiotiki; 1974 Aug; 19(8):759-62. PubMed ID: 4375945 [No Abstract] [Full Text] [Related]
5. Enhancement of interferon induction in mice by polycationic modified polypeptides. Mécs I; Gánti T; Kótai A Acta Virol; 1976 Apr; 20(2):164-6. PubMed ID: 5874 [TBL] [Abstract][Full Text] [Related]
6. The dynamics of virological and serological indices in primary herpetic keratitis in rabbits treated with antiviral drugs. Zaitseva NS; Muravieva TV; Vinogradova VL; Kasparov AA; Fadeeva LL; Oganesyan RK Acta Virol; 1973 May; 17(3):220-6. PubMed ID: 4125848 [No Abstract] [Full Text] [Related]
7. Antiviral chemotherapy. Med Lett Drugs Ther; 1971 Sep; 13(19):77-8. PubMed ID: 4328547 [No Abstract] [Full Text] [Related]
8. Polymeric drugs: direct compared with indirect inhibition of leukemia virus replication in mice. Vengris VE; Pitha PM; Sensenbrenner LL Mol Pharmacol; 1978 Mar; 14(2):271-7. PubMed ID: 205772 [No Abstract] [Full Text] [Related]
9. Antiviral and interferon-inducing properties of interferon inducers administered with prostaglandins. Stringfellow DA Antimicrob Agents Chemother; 1980 Mar; 17(3):455-60. PubMed ID: 6158913 [TBL] [Abstract][Full Text] [Related]
10. Interferon induction by, and antiviral effect of poly (rI)--poly (rC) in experimental viral infection. Tazulakhova EB; Novokhatsky AS; Yershov FI Acta Virol; 1973 Nov; 17(6):487-92. PubMed ID: 4150030 [No Abstract] [Full Text] [Related]
11. [Prospects in the use of the interferon system in the prevention and treatment of viral infections]. Dianzani F; Viano I; Zucca M G Ital Chemioter; 1974; 21(2):67-78. PubMed ID: 4471329 [No Abstract] [Full Text] [Related]
12. [Interferon and so-called interferon inducers]. Havemann K Wien Klin Wochenschr; 1973 Jun; 85(26):461-6. PubMed ID: 4577809 [No Abstract] [Full Text] [Related]
13. Antiviral chemotherapy. Bauer DJ Mod Trends Med Virol; 1967; 1(0):49-76. PubMed ID: 4950642 [No Abstract] [Full Text] [Related]
14. Amelioration of friend virus leukemia by sequential administration of viral and nonviral interferon inducers. Barker AD; Rheins MS; Wilson HE Proc Soc Exp Biol Med; 1971 Jul; 137(3):981-7. PubMed ID: 5105377 [No Abstract] [Full Text] [Related]
15. Prospects for the clinical use of exogenous interferon. Cantell K Med Biol; 1977 Apr; 55(2):69-73. PubMed ID: 194114 [TBL] [Abstract][Full Text] [Related]
16. [Artificial polynucleotides as inducers of interferon]. Heidel G Z Gesamte Hyg; 1974 Feb; 20(2):116. PubMed ID: 4598964 [No Abstract] [Full Text] [Related]
18. A future for exogenous interferon therapy? Weimar W; Schellekens H Neth J Med; 1978; 21(6):275-8. PubMed ID: 732919 [No Abstract] [Full Text] [Related]
19. [Interferon, inducers of its formation -- interferonogens and prospects of their use in viral diseases of the eye (literature survey)]. Zeĭtlenok NA; Vil'ner LM; Kasparov AA Vestn Oftalmol; 1966; 79(6):80-3. PubMed ID: 4296552 [No Abstract] [Full Text] [Related]
20. The role of interferon in the spontaneous regression of Friend virus induced leukemia. Furmanski P; Juni S; Hall L; Rich MA Proc Soc Exp Biol Med; 1975 Oct; 150(1):11-13. PubMed ID: 1237890 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]